Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.17 +0.06 (+0.37%)

Streaming Delayed Price Updated: 11:03 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

Today 7:00 EDT

From Bausch + Lomb Corporation

Via Business Wire

3 Profitable Stocks We’re Skeptical Of

May 18, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

May 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second R&D “Teach-in” Webinar

May 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance ↗

April 29, 2026

Via Chartmill

Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript ↗

April 30, 2026

Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript

Via The Motley Fool

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

April 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

April 29, 2026

Eyecare company Bausch + Lomb (NYSE:BLCO) announced better-than-expected revenue in Q1 CY2026, with sales up 9.4% year on year to $1.24 billion. The company’...

Via StockStory

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

April 29, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

April 27, 2026

Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings this Wednesday before the bell. Here’s what to expect. Bausch + Lomb beat analysts’ reve...

Via StockStory

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

April 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Releases 2025 Sustainability Impact Report

April 22, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch Lomb BLCO Q2 2025 Earnings Transcript ↗

April 21, 2026

Bausch Lomb BLCO Q2 2025 Earnings Transcript

Via The Motley Fool

Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript ↗

April 21, 2026

Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript

Via The Motley Fool

Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript ↗

April 21, 2026

Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Initial Public Offering

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program

April 16, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Cash-Burning Stocks We Keep Off Our Radar

April 10, 2026

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses...

Via StockStory

Topics Bankruptcy

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

April 08, 2026

From Bausch + Lomb Corporation

Via Business Wire

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

April 08, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...

Via StockStory

Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe

April 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting

April 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks

April 01, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Bausch + Lomb (NYSE:BLCO) and...

Via StockStory

Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29

March 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Reasons BLCO is Risky and 1 Stock to Buy Instead

March 26, 2026

Even during a down period for the markets, Bausch + Lomb has gone against the grain, climbing to $16.01. Its shares have yielded a 10.4% return over the last...

Via StockStory

Topics Bankruptcy

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story ↗

March 24, 2026

Bausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.

Via The Motley Fool

Topics Regulatory Compliance

Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

March 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Billboard Giant Posts $1.6 Billion Revenue as $20.5 Million Bet Makes It a Top Portfolio Holding ↗

March 12, 2026

This outdoor advertising firm operates a vast network of displays across the Americas and Europe, serving a diverse global client base.

Via The Motley Fool

Topics Regulatory Compliance

Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position ↗

March 12, 2026

Bausch + Lomb provides eye health products and surgical devices globally, serving both healthcare professionals and consumers.

Via The Motley Fool

Topics Regulatory Compliance

Bausch + Lomb Launches R&D “Teach-in” Webinar Series

March 09, 2026

From Bausch + Lomb Corporation

Via Business Wire

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

March 06, 2026

Via StockStory

Topics Earnings Economy

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.